1. Medtech Insight

Synergetics continues Codman/VFS partnership

Synergetics USA has entered into a three-year agreement with Johnson & Johnson-subsidiary Codman & Shurtleff for the distribution of certain Synergetics bipolar generators and its related accessories. The contract marks the continuation of Codman's previous 20-year partnership with Valley Forge Scientific before the latter combined with Synergetics in September last year to form Synergetics USA.

Synergetics USA has entered into a three-year agreement with Johnson & Johnson-subsidiary Codman & Shurtleff for the distribution of certain Synergetics bipolar generators and its related accessories. The contract marks the continuation of Codman's previous 20-year partnership with Valley Forge Scientific before the latter combined with Synergetics in September last year to form Synergetics USA.

Under the new distribution deal, which is forecast to generate around $6.5m in first-year sales, Codman will gain exclusive rights...

More from Archive

More from Medtech Insight

EU Pilot Features ‘All-In-One’ Regulatory Path For Drug/Diagnostic Trials

 
• By Vibha Sharma

The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.

European Medtechs Reiterate Opposition To Reciprocal Tariffs On US Imports

 
• By Ashley Yeo

EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.